Skip to content

News

The Institute of Medicine Reports on Ovarian Cancer

The Institute of Medicine Reports on Ovarian Cancer

The Institute of Medicine (IOM) recently released a report commissioned by Congress, Ovarian Cancers: Evolving Paradigms in Research and Care. The report provides an in-depth look at the state of ovarian cancer in the United States. While significant progress has been made in the fight against ovarian cancer in the last few decades, the report … Continued

Dose-dense Weekly Paclitaxel Does Not Increase PFS

Dose-dense Weekly Paclitaxel Does Not Increase PFS

(March 3, 2016) In a study published in the New England Journal of Medicine this week, researchers report that a dose-dense weekly paclitaxel regimen failed to improve progression-free survival in advanced ovarian cancer versus a conventional regimen and optional bevacizumab (Avastin). Patients treated with weekly paclitaxel plus carboplatin had a median PFS of 14.7 months compared … Continued

The Minnesota Ovarian Cancer Alliance

The Minnesota Ovarian Cancer Alliance

The Minnesota Ovarian Cancer Alliance (MOCA) formed in 1999, when a small group of survivors, united by their doctors, gathered around a dining room table. They realized the lack of ovarian cancer support in their community, and were intent on building a Minnesota ovarian cancer community, made up of survivors and caregivers. The founders were … Continued

Rockin 4A Cause

Rockin 4A Cause

Rockin 4A Cause was founded by 4 couples who had each lost someone very close to them to three different diseases, including most recently Dyan Elovich Blumberg to ovarian cancer. Together, they found a reason to rock and raise funds with their favorite music with all of their favorite people for 3 important causes. This … Continued

Clinical Trial Highlight: Long-Term Survivor Study

Clinical Trial Highlight: Long-Term Survivor Study

Official Trial Name:  The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer – Recruitment. Some advanced-stage ovarian cancer patients are long-term survivors of stages III and IV serum ovarian cancer. These patients may provide the key to long-term survival and bring hope to all women with Stages III and IV ovarian cancer. … Continued

OCRF Research Illuminates Origins of PPM1D Mutations in Ova...

OCRF Research Illuminates Origins of PPM1D Mutations in Ovarian Cancer Patients

(February 24, 2016) Research led by Dr. Elizabeth Swisher at the University of Washington, funded in part by OCRFA and published this month in JAMA Oncology, shows that mutations in the gene PPM1D in women with ovarian cancer are the result of aging and chemotherapy exposure. Read the abstract in JAMA Oncology. Previously, somatic mosaic … Continued

Research News: Talcum Powder

Research News: Talcum Powder

The Ovarian Cancer Research Alliance provides information based on medical research and best practices. Research regarding a connection between the use of talcum powder and increased ovarian cancer risk is inconclusive. The verdict of a recent trial regarding talcum powder. will not change the information that the Ovarian Cancer Research Alliance provides to women about talcum … Continued

OCRF Research Defines How Satb1 Gene Goes from Helpful to H...

OCRF Research Defines How Satb1 Gene Goes from Helpful to Harmful in Ovarian Cancer

(February 22, 2016) Imagine a lighthouse on cancer cells that can tell the T-cells in our immune system precisely where to attack to stop cancer in its tracks. When working properly, that’s exactly what dendritic cells do. They break down cancer cells into antigens that T-cells can “read” and know to attack while sparing healthy … Continued

Advocacy for Ovarian Cancer: Let Your Voice Be Heard!

Advocacy for Ovarian Cancer: Let Your Voice Be Heard!

Check out our webinar by Chad Ramsey, VP of Policy, and Alison Silberman, Director of Field Engagement, to learn about OCRFA’s legislative efforts in 2016. You’ll hear about the issues we are working on and learn about ways you can get involved to help make a difference for women with ovarian cancer. Watch more webinars.

President Asks for $1B to Fund Cancer “Moon Shot”

President Asks for $1B to Fund Cancer “Moon Shot”

In his final State of the Union address, President Obama announced a national initiative to find a cure to cancer. Details are beginning to emerge about the plan and the President has requested $1 Billion in new funding over the next two years to boost the effort.  As Congress begins to consider annual appropriations legislation, … Continued

The Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation (SROCF) humbly began 15 years ago, on a living room floor, with the goal to give women a fighting chance against ovarian cancer. At the heart of the foundation is Sandy Rollman, a remarkable woman who lost her battle to ovarian cancer in 2000 at far too young an … Continued

Strength in Numbers: OCRF and OCNA Unite to Form OCRFA

Strength in Numbers: OCRF and OCNA Unite to Form OCRFA

As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families.

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.